Showing results (881-890 of 917) with videos related to

Sort By:
Pageof 92
Nature Communications|March 8, 2018
Context-dependent interactions and the regulation of species richness in freshwater fishAndrew S MacDougall, Eric Harvey, Jenny L McCune, et al.
Annals of Surgery|February 29, 2024
Survival and Quality of Life After Isolated Hepatic Perfusion With Melphalan as a Treatment for Uveal Melanoma Liver Metastases: Final Results From the Phase III Randomized Controlled Trial SCANDIUMRoger Olofsson Bagge, Axel Nelson, Amir Shafazand, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
The inhomogeneous structure of water at ambient conditionsC Huang, K T Wikfeldt, T Tokushima, et al.
Leukemia|March 12, 2026
High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insightsH Parker, L Carr, K Norris, et al.
The Journal of Physical Chemistry Letters|August 2, 2017
Real-Time Elucidation of Catalytic Pathways in CO Hydrogenation on RuJ LaRue, O Krejčí, L Yu, et al.
JCO Precision Oncology|September 11, 2020
Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown PrimaryRoger Olofsson Bagge, Akif Demir, Joakim Karlsson, et al.
Pigment Cell & Melanoma Research|June 24, 2026
Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025Andrew E Aplin, Katherina Alsina, Allison S Betof, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 17, 2024
The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib/II randomized double-blind placebo-controlled trial (NivoILP trial)Carl-Jacob Holmberg, Lisanne P Zijlker, Dimitrios Katsarelias, et al.
The Journal of Clinical Investigation|September 17, 2024
Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical modelsZhi-Jie Li, Bo He, Alice Domenichini, et al.
Cell Death & Disease|February 8, 2020
Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanomaBerglind O Einarsdottir, Joakim Karlsson, Elin M V Söderberg, et al.
Pageof 92